What is the initial workup and treatment for a patient presenting with a seizure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Workup and Treatment for Seizure Presentation

For patients presenting with a first-time seizure, perform neuroimaging in the ED when feasible, obtain serum glucose and sodium levels, and discharge patients who have returned to baseline with reliable outpatient follow-up rather than routinely admitting or starting antiepileptic drugs. 1

Immediate Stabilization and Assessment

Time the seizure duration immediately - status epilepticus is defined as seizure lasting >5 minutes or multiple seizures without return to baseline, requiring emergent benzodiazepine administration. 2

Keep the patient NPO until swallowing ability is formally assessed to prevent aspiration, as seizures can temporarily impair swallowing function. 3, 2

Laboratory Workup

The laboratory evaluation should be targeted rather than routine:

  • Obtain serum glucose and sodium levels - these are the most frequent metabolic abnormalities identified in new-onset seizures and directly guide management. 1

  • Obtain pregnancy test if the patient has reached menarche, as this fundamentally changes management decisions. 1

  • Consider toxicology screening only if there is clinical suspicion of drug exposure or substance abuse based on history or examination findings. 1

  • Additional laboratory tests (CBC, comprehensive metabolic panel, calcium) should be obtained only when suggested by specific clinical findings such as vomiting, diarrhea, dehydration, or fever - not routinely. 1, 4

The evidence shows that while 23% of patients have abnormal physical examinations and various percentages have laboratory abnormalities, only glucose and sodium abnormalities consistently alter acute management. 4

Neuroimaging Strategy

Perform CT head without contrast emergently when any of these high-risk features are present: 4, 1

  • New focal neurological deficits
  • Persistent altered mental status
  • Fever
  • Recent head trauma
  • Persistent headache
  • History of malignancy or immunocompromised state
  • Anticoagulation use
  • Age >40 years
  • Partial-onset (focal) seizure before generalization

MRI is the preferred imaging modality for non-emergent evaluation when the patient has returned to baseline, as it provides superior detection of structural abnormalities. 1

Deferred outpatient neuroimaging is acceptable for patients who have returned to baseline, have normal neurologic examination, and have reliable follow-up arrangements. 4

The evidence demonstrates that 41% of first-time seizure patients have abnormal CT findings, and 22% with normal neurologic examinations still have abnormal imaging, but immediate ED imaging primarily impacts disposition rather than mortality. 4

Lumbar Puncture Indications

Perform lumbar puncture only when there is specific concern for: 1

  • Meningitis or encephalitis (fever, persistent altered mental status, meningeal signs)
  • Immunocompromised patients (after CT to rule out mass effect)

Routine lumbar puncture is not indicated for uncomplicated first-time seizures. 4

EEG Timing

EEG should be obtained as part of the neurodiagnostic evaluation but does not need to be performed emergently in the ED. 1 Abnormal EEG findings predict increased seizure recurrence risk but do not change acute ED management. 1

Disposition Decisions

Emergency physicians need not admit patients with a first unprovoked seizure who have returned to their clinical baseline in the ED. 1

Consider admission only if any of the following persist: 1

  • Abnormal neurologic examination
  • Abnormal investigation results requiring inpatient management
  • Patient has not returned to baseline

The recurrence risk data shows that 19% of patients have seizure recurrence within 24 hours, decreasing to 9% when alcohol-related events and focal CT lesions are excluded. 4 However, the mean time to first recurrence is 121 minutes (median 90 minutes) with 85% occurring within 6 hours. 1, 3

Antiepileptic Drug Initiation

Do not routinely initiate antiepileptic drugs in the ED for patients with a first unprovoked seizure who have returned to baseline. 2

The evidence demonstrates that antiepileptic drug treatment reduces 1-2 year recurrence risk but does not affect long-term recurrence rates or remission rates. 4 Starting treatment for a single seizure exposes patients to medication adverse effects without proven mortality or morbidity benefit.

For status epilepticus or ongoing seizures, the treatment algorithm is: 2

  1. First-line: Benzodiazepines (lorazepam or diazepam)
  2. Second-line: Phenytoin/fosphenytoin, valproate, or levetiracetam
  3. Refractory: Consider propofol or barbiturates

Valproate (30 mg/kg) is as effective as phenytoin with potentially fewer adverse effects like hypotension. 1

Common Pitfalls to Avoid

  • Failing to identify hypoglycemia or hyponatremia - these reversible causes must be checked and corrected immediately. 1

  • Allowing oral intake before swallowing assessment - this can lead to aspiration pneumonia, particularly after multiple seizures. 3

  • Missing structural lesions by omitting neuroimaging in high-risk patients (age >40, focal features, trauma, immunocompromised). 1

  • Delaying benzodiazepines in status epilepticus - treatment should begin immediately when seizure duration exceeds 5 minutes. 2

  • Routinely admitting or starting antiepileptic drugs for uncomplicated first seizures - this exposes patients to unnecessary hospitalization costs and medication side effects without proven benefit. 1, 2

References

Guideline

Evaluation and Management of New Onset Seizures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Approach to a Patient with Seizure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of NPO Status in Patients with Multiple Seizures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.